drugset / Trial / NCT06480981
Multiple Ascending Dose Noribogaine PK/PD in Healthy Volunteers
RandomizedSequentialTriple-blindOther
Summary
This trial will be a randomised, double-blind, sequential-group, multiple-dose, placebo-controlled, dose escalation trial to characterise the pharmacokinetics (PK), pharmacodynamics (PD) and safety of noribogaine in healthy adult participants.
Timeline
- Start
- 2024-06-20
- Primary completion
- 2024-12-23
- Completion
- 2025-01-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Noribogaine | Small molecule | 20 mg | — |
| Subject | Noribogaine | Small molecule | 40 mg | — |
| Subject | Noribogaine | Small molecule | 60 mg | — |
| Subject | Noribogaine | Small molecule | 80 mg | — |
Indications
No indication recorded.